Heron Therapeutics(DE:AXD2)
€0.33+0.08 (+34.15%)
DE:AXD2
Heron Therapeutics earnings date
€0.33
At close:+0.08 (+34.15%)
Heron Therapeutics (AXD2) Q3 2019 Earnings Report
4 Followers
DE:AXD2 Q3 2019 EPS Results
- Actual EPS
- -EUR 0.38
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.44
DE:AXD2 Q3 2019 Revenue Results
- Actual Revenue
- EUR 38.16M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +115.43%
Earnings Announcement Details
- Quarter
- Q3 2019
- Date
- 11/12/2019
- Time
- Before Open
- Conference Call
- Tuesday, November 12, 2019
DE:AXD2 Upcoming Earnings
Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AXD2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.03- | -0.02 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.02-0.03 | -0.09 | 70.00% (+0.06) | |
| Aug 10, 2026 | 2026 (Q2) | -0.00-0.03 | -0.02 | -50.00% (-0.01) | |
| May 11, 2026 | 2026 (Q1) | -0.02-0.04 | 0.01 | -500.00% (-0.04) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.02 | 0.02 | -200.00% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | -0.01-0.09 | -0.03 | -233.33% (-0.06) | |
| Aug 08, 2025 | 2025 (Q2) | -0.01-0.02 | -0.05 | 66.67% (+0.04) | |
| May 06, 2025 | 2025 (Q1) | -0.010.01 | -0.02 | 150.00% (+0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -0.030.02 | -0.06 | 128.57% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.03-0.03 | -0.15 | 82.35% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
